Pod1 Pharmacovigilance Flashcards

1
Q

What is pharmacovigilance?

A

The process of identifying and then responding to safety issues about marketed drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give 3 aims of pharmacovigilance

A

Identify previously unknown drug hazards
Find factors that lead to ADRs
Attain new evidence of drug safety so it can be used more widely
Prove previously toxic drugs to be safe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a Type A ADR?

A

Exaggerated pharmacological response which is predictable, dose dependant and common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a Type B ADR?

A

Not expected from the pharmacology, unpredictable, independent of dose, rare and often severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why are some ADRs only picked up after clinical trials?

A

In clinical trials, the rug will be tested on approximately 3000 patients. For ADRs which are rare and only occur in >1 in 5000 patients, the clinical trials will not pick it up. The ADR is only recognised when the drug is introduced into the general population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Other than sample size, give 2 reasons why an ADR may only be picked up after clinical trials have finished

A

A wider range of patients take the drug- eg. not patients specially selected for a trial
Treatment lasts much longer than the clinical trial period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is spontaneous reporting?

A

The doctor or patient reporting a drug side effect in order to establish a possible ADR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the Yellow Card Scheme?

A

A program which allows ADRs to be reported for high-risk and new drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give 5 advantages of spontaneous reporting

A
Operates as soon as drug is marketed
Covers entire population 
Involves all doctors
Overlooks all drugs
Detects rare and common ADRs
Inexpensive
Can use to identify risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give 5 limitations of spontaneous reporting

A
Large under-reporting
Delays in reporting
Poor quality data
Misleading reports
No control group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a cohort study?

A

A control group is compared against a group of patients taking the drug. They are followed forward in time and compared to see potential side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a case control study?

A

Cases with an adverse event are looked at retrospectively and compared with controls to expose causality with a risk factor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give 3 advantages of a case control study

A

Good for rare ADRs
Can give a quick answer
Low cost
Indicate degree of increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give 3 disadvantages of ADRs

A

Requires prior hypothesis
Many biases
Need expertise
Needs credibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give 7 reasons why ADRs are under-reported

A
FAILURE
Failure of patient to tell doctor
ADR too trivial
Ignorance of reporting- don't know how
Lack of time
Uncertainty of relationship of drug to presentation 
Relating to duration of marketed drug
Experience and familiarity with the ADR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the MHRA?

A

Group responsible for drug licensing in the UK

17
Q

What is the role of NICE in drug licensing?

A

Choose which drug should be the first-line treatment